Brief: Mannkind Corp Reports 2022 Third Quarter Financial Results
Nov 8 (Reuters) - Mannkind Corp MNKD.O :
* ORATION REPORTS 2022 THIRD QUARTER FINANCIAL RESULTS
* 3Q 2022 TOTAL REVE $32.8 MILLION; +48% VERSUS. 3Q 2021
* QTRLY LOSS PER SHARE$0.06
* Q3 EARNINGS PER SHARE VIEW $-0.09, REVENUE VIEW $25.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbvbjmd
Further company coverage: MNKD.O
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children